Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy, Rituximab, and Bexxar in High-Risk B-Cell NHL
NCT00577629Phase 2Completed
- Sponsor
- Duke University
- Start
- Jun 2005
- Primary completion
- Apr 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of tositumomab in B-cell non-Hodgkin lymphoma, sponsored by Duke University. Started Jun 2005; status: completed.
02
Drugs
tositumomab
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT00577629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00577629.